164 related articles for article (PubMed ID: 26509557)
1. MARVELD1 modulates cell surface morphology and suppresses epithelial-mesenchymal transition in non-small cell lung cancer.
Yao Y; Shi M; Liu S; Li Y; Guo K; Ci Y; Liu W; Li Y
Mol Carcinog; 2016 Nov; 55(11):1714-1727. PubMed ID: 26509557
[TBL] [Abstract][Full Text] [Related]
2. Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-β1-mediated epithelial to mesenchymal transition in lung cancer cells.
Li L; Yan S; Zhang H; Zhang M; Huang G; Chen M
BMC Cancer; 2019 Sep; 19(1):894. PubMed ID: 31492158
[TBL] [Abstract][Full Text] [Related]
3. The depletion of MARVELD1 leads to murine placenta accreta via integrin β4-dependent trophoblast cell invasion.
Chen Y; Zhang H; Han F; Yue L; Qiao C; Zhang Y; Dou P; Liu W; Li Y
J Cell Physiol; 2018 Mar; 233(3):2257-2269. PubMed ID: 28708243
[TBL] [Abstract][Full Text] [Related]
4. Pirfenidone plays a biphasic role in inhibition of epithelial-mesenchymal transition in non-small cell lung cancer.
Fujiwara A; Shintani Y; Funaki S; Kawamura T; Kimura T; Minami M; Okumura M
Lung Cancer; 2017 Apr; 106():8-16. PubMed ID: 28285699
[TBL] [Abstract][Full Text] [Related]
5. RCCD1 depletion attenuates TGF-β-induced EMT and cell migration by stabilizing cytoskeletal microtubules in NSCLC cells.
Wu J; He Z; Yang XM; Li KL; Wang DL; Sun FL
Cancer Lett; 2017 Aug; 400():18-29. PubMed ID: 28455245
[TBL] [Abstract][Full Text] [Related]
6. β1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells.
Morello V; Cabodi S; Sigismund S; Camacho-Leal MP; Repetto D; Volante M; Papotti M; Turco E; Defilippi P
Oncogene; 2011 Sep; 30(39):4087-96. PubMed ID: 21478906
[TBL] [Abstract][Full Text] [Related]
7. MARVELD1 regulates integrin β1-mediated cell adhesion and actin organization via inhibiting its pre-mRNA processing.
Wang S; Hu J; Yao Y; Shi M; Yue L; Han F; Zhang H; He J; Liu S; Li Y
Int J Biochem Cell Biol; 2013 Nov; 45(11):2679-87. PubMed ID: 24055813
[TBL] [Abstract][Full Text] [Related]
8. Effects of FOXJ2 on TGF-β1-induced epithelial-mesenchymal transition through Notch signaling pathway in non-small lung cancer.
Yang Q; Cao X; Tao G; Zhou F; Zhao P; Shen Y; Chen X
Cell Biol Int; 2017 Jan; 41(1):79-83. PubMed ID: 27611107
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2 upregulates β1 integrin expression via the E prostanoid 1 receptor/nuclear factor κ-light-chain-enhancer of activated B cells pathway in non-small-cell lung cancer cells.
Bai X; Yang Q; Shu W; Wang J; Zhang L; Ma J; Xia S; Zhang M; Cheng S; Wang Y; Leng J
Mol Med Rep; 2014 May; 9(5):1729-36. PubMed ID: 24584670
[TBL] [Abstract][Full Text] [Related]
10. Early Growth Response Protein-1 Involves in Transforming Growth factor-β1 Induced Epithelial-Mesenchymal Transition and Inhibits Migration of Non-Small-Cell Lung Cancer Cells.
Shan LN; Song YG; Su D; Liu YL; Shi XB; Lu SJ
Asian Pac J Cancer Prev; 2015; 16(9):4137-42. PubMed ID: 25987100
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
[TBL] [Abstract][Full Text] [Related]
12. miR-16 mimics inhibit TGF-β1-induced epithelial-to-mesenchymal transition via activation of autophagy in non-small cell lung carcinoma cells.
Wang H; Zhang Y; Wu Q; Wang YB; Wang W
Oncol Rep; 2018 Jan; 39(1):247-254. PubMed ID: 29138833
[TBL] [Abstract][Full Text] [Related]
13. FMNL1 down-regulation suppresses bone metastasis through reducing TGF-β1 expression in non-small cell lung cancer (NSCLC).
Yang XY; Liao JJ; Xue WR
Biomed Pharmacother; 2019 Sep; 117():109126. PubMed ID: 31387165
[TBL] [Abstract][Full Text] [Related]
14. Decitabine reverses TGF-β1-induced epithelial-mesenchymal transition in non-small-cell lung cancer by regulating miR-200/ZEB axis.
Zhang N; Liu Y; Wang Y; Zhao M; Tu L; Luo F
Drug Des Devel Ther; 2017; 11():969-983. PubMed ID: 28405157
[TBL] [Abstract][Full Text] [Related]
15. Kaempferol Suppresses Transforming Growth Factor-β1-Induced Epithelial-to-Mesenchymal Transition and Migration of A549 Lung Cancer Cells by Inhibiting Akt1-Mediated Phosphorylation of Smad3 at Threonine-179.
Jo E; Park SJ; Choi YS; Jeon WK; Kim BC
Neoplasia; 2015 Jul; 17(7):525-37. PubMed ID: 26297431
[TBL] [Abstract][Full Text] [Related]
16. HPIP silencing inhibits TGF-β1-induced EMT in lung cancer cells.
Shi S; Zhao J; Wang J; Mi D; Ma Z
Int J Mol Med; 2017 Feb; 39(2):479-483. PubMed ID: 28075456
[TBL] [Abstract][Full Text] [Related]
17. FPPS mediates TGF-β1-induced non-small cell lung cancer cell invasion and the EMT process via the RhoA/Rock1 pathway.
Lin L; Li M; Lin L; Xu X; Jiang G; Wu L
Biochem Biophys Res Commun; 2018 Feb; 496(2):536-541. PubMed ID: 29337059
[TBL] [Abstract][Full Text] [Related]
18. Drug-resistant CXCR4-positive cells have the molecular characteristics of EMT in NSCLC.
Yin H; Wang Y; Chen W; Zhong S; Liu Z; Zhao J
Gene; 2016 Dec; 594(1):23-29. PubMed ID: 27581786
[TBL] [Abstract][Full Text] [Related]
19. Ursolic Acid Attenuates TGF-β1-Induced Epithelial-Mesenchymal Transition in NSCLC by Targeting Integrin αVβ5/MMPs Signaling.
Ruan JS; Zhou H; Yang L; Wang L; Jiang ZS; Sun H; Wang SM
Oncol Res; 2019 May; 27(5):593-600. PubMed ID: 28911340
[TBL] [Abstract][Full Text] [Related]
20. Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway.
Da C; Liu Y; Zhan Y; Liu K; Wang R
Oncol Rep; 2016 May; 35(5):2767-74. PubMed ID: 26986176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
